Reliance Crushes Q2 Estimates, Lifts Q3 Guidance on Border Wall Surge
RS sits 48% above its 52-week low of $260.31.
Summary
Reliance posted a massive Q2 beat with sales up 26.5% to $4.63B and adjusted EPS of $6.27, crushing consensus by 16%. Q3 guidance of $6.40–$6.60 implies 76–81% YoY growth, driven by the U.S. border wall project and broad-based demand strength.
Key Events · Earnings and Guidance · RS
-
Q2 Earnings Massively Beat
Net sales of $4.63B (up 26.5% YoY) and non-GAAP EPS of $6.27—well above the $5.15–$5.35 guidance—were powered by record tons sold of 1.79M, a 10.8% YoY increase, and strong pricing.
-
Border Wall Project Doubles Contribution
The U.S. border wall project contributed $0.41 EPS in Q2, more than double the expected $0.15–$0.20, and is expected to add $0.60 EPS in Q3.
-
Q3 Guidance Raised Significantly
Q3 non-GAAP EPS guidance of $6.40–$6.60 implies 76–81% YoY growth, with tons sold up 9–11% YoY and ASP flat to up 2% sequentially.
-
Capital Returns: Dividend Up, Buybacks Paused
The quarterly dividend was raised to $1.25/share, payable August 28. No share repurchases occurred in Q2, but $529M remains authorized under the buyback program.
Analysis · RS · Trade & Services
A massive Q2 beat saw sales jump 26.5% to $4.63B and adjusted EPS reach $6.27, crushing consensus by 16%. The U.S. border wall project delivered $0.41 per share—more than double management's forecast—and is poised to contribute $0.60 in Q3. Guidance for the third quarter of $6.40–$6.60 implies 76–81% year-over-year growth, well ahead of Street expectations. Record tons sold and firm pricing across carbon steel and aluminum fueled the outperformance. The balance sheet remains fortress-like at 0.9x net debt/EBITDA, and while buybacks were paused this quarter, $529M remains authorized. This is a thesis-altering quarter that confirms Reliance as a prime beneficiary of infrastructure and defense spending.
At the time of this filing, RS was trading at $386.21 on NYSE in the Trade & Services sector, with a market capitalization of approximately $19.7B. The 52-week trading range was $260.31 to $419.83. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.